サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1469860

タンパク質工学の世界市場：産業分析、規模、シェア、成長、動向、予測（2024～2032年）

Global Protein Engineering Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日: | 発行: Value Market Research | ページ情報: 英文 283 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
タンパク質工学の世界市場：産業分析、規模、シェア、成長、動向、予測（2024～2032年）
出版日: 2024年04月01日
発行: Value Market Research
ページ情報: 英文 283 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のタンパク質工学の市場規模は、2023年に20億9,000万米ドルに達し、2024～2032年の予測期間中にCAGR 17.23%で成長し、2032年には87億4,000万米ドルに達すると予測されています。

タンパク質工学は、特定の用途のためにタンパク質を設計、修正、最適化することに焦点を当てたバイオテクノロジー分野です。分子モデリング、合理的設計、定向進化、組換えDNA技術などを駆使して、望ましい特性や機能性を持つタンパク質を作り出します。治療用タンパク質、酵素、ワクチン、バイオセンサー、バイオマテリアルの開発など、医学、農業、工業、バイオテクノロジーにおける多様な応用があります。タンパク質の構造と機能の原理を利用することで、タンパク質工学は安定性、活性、特異性、その他の望ましい特性を改善した新規分子の設計を可能にします。

市場力学

がん、自己免疫疾患、感染症など様々な疾患の治療用タンパク質やバイオ医薬品に対する需要の高まりが、タンパク質の機能、安定性、薬物動態を最適化する革新的なタンパク質工学技術の必要性を高めています。さらに、合理的設計、定向進化、計算モデリングなどのタンパク質工学技術の進歩は、有効性、特異性、安全性プロファイルを強化した新規タンパク質ベースの治療薬の開発を可能にします。さらに、製薬会社、学術機関、政府機関によるバイオテクノロジー研究開発への投資が拡大していることも、技術革新に拍車をかけ、タンパク質工学技術の商業化を後押ししています。

さらに、産業用生体触媒のための酵素工学、生体材料やドラッグデリバリーシステムのためのタンパク質設計、農業バイオテクノロジーのためのタンパク質の最適化など、治療薬以外のタンパク質工学の用途が拡大していることが、新たな市場機会を生み出し、成長を促進しています。個別化医療、診断、再生医療におけるタンパク質工学技術の採用が増加していることも、市場拡大の原動力となっています。さらに、企業、バイオ医薬品企業、研究機関の戦略的提携や協力関係がイノベーションを促進し、タンパク質ベースの製品の開発と商業化を加速しています。しかし、医療機器におけるプライバシーやデータセキュリティに関する懸念が、今後数年間の市場成長の課題となる可能性があります。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を取り上げています。これらのツールは、産業の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、タンパク質工学の世界市場における各セグメントを包括的に評価することもできます。タンパク質工学産業の成長と動向は、この調査に全体的なアプローチを提供します。

市場セグメンテーション

タンパク質工学市場レポートのこのセクションでは、国および地域レベルのセグメントに関する詳細なデータを提供し、それによって戦略家がそれぞれの製品またはサービスのターゲット層を特定する上で、今後の機会を支援します。

製品別

  • 器具
  • 試薬
  • ソフトウェア・サービス

技術別

  • 合理的タンパク質設計
  • 指向性進化
  • ハイブリッドアプローチ
  • デノボ蛋白質設計
  • その他

タンパク質タイプ別

  • インスリン
  • モノクローナル抗体
  • ワクチン
  • 成長因子
  • コロニー刺激因子
  • 凝固因子
  • インターフェロン
  • その他

用途別

  • 学術研究機関
  • 受託研究機関
  • 製薬・バイオテクノロジー企業

地域分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおけるタンパク質工学市場の現在と将来の需要を強調する地域展望をカバーしています。さらに、著名な全地域における個々のアプリケーションセグメントの需要・推定・予測にも焦点を当てています。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 タンパク質工学 - 産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 産業動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 タンパク質工学の世界市場分析：製品別

  • 概要：製品別
  • 実績データと予測データ
  • 分析：製品別
  • 器具
  • 試薬
  • ソフトウェア・サービス

第6章 タンパク質工学の世界市場分析：技術別

  • 概要：技術別
  • 実績データと予測データ
  • 分析：技術別
  • 合理的タンパク質設計
  • 指向性進化
  • ハイブリッドアプローチ
  • デノボ蛋白質設計
  • その他

第7章 タンパク質工学の世界市場分析：タンパク質タイプ別

  • 概要：タンパク質タイプ別
  • 実績データと予測データ
  • 分析：タンパク質タイプ別
  • インスリン
  • モノクローナル抗体
  • ワクチン
  • 成長因子
  • コロニー刺激因子
  • 凝固因子
  • インターフェロン
  • その他

第8章 タンパク質工学の世界市場分析：最終用途別

  • 概要：最終用途別
  • 実績データと予測データ
  • 分析：最終用途別
  • 学術研究機関
  • 受託研究機関
  • 製薬・バイオテクノロジー企業

第9章 タンパク質工学の世界市場分析：地域別

  • 展望：地域別
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第10章 タンパク質工学企業の競合情勢

  • タンパク質工学市場の競合
  • 提携・協力・合意
  • 合併・買収
  • 新製品上市
  • その他の開発

第11章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Agilent Technologies
  • Bruker Corp.
  • Thermo Fisher Scientific Inc.
  • PerkinElmer Inc.
  • Waters Corp.
  • Bio-Rad Laboratories
  • Merck KGaA
  • Danaher Corp.
  • Genscript Biotech Corp
  • Amgen Inc.
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Reagents Market Sales By Geography (USD MN)
  • Software & Services Market Sales By Geography (USD MN)
  • Analysis By Technology (USD MN)
  • Rational Protein Design Market Sales By Geography (USD MN)
  • Directed Evolution Market Sales By Geography (USD MN)
  • Hybrid Approach Market Sales By Geography (USD MN)
  • De Novo Protein Design Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Protein Type (USD MN)
  • Insulin Market Sales By Geography (USD MN)
  • Monoclonal Antibodies Market Sales By Geography (USD MN)
  • Vaccines Market Sales By Geography (USD MN)
  • Growth Factors Market Sales By Geography (USD MN)
  • Colony Stimulating Factors Market Sales By Geography (USD MN)
  • Coagulation Factors Market Sales By Geography (USD MN)
  • Interferon Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Academic Research Institutes Market Sales By Geography (USD MN)
  • Contract Research Organizations (CROs) Market Sales By Geography (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Global Protein Engineering Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Protein Engineering Report
  • Market Research Process
  • Market Research Methodology
  • Global Protein Engineering Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Technology
  • Market Attractiveness Analysis By Protein Type
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Reagents Market Sales By Geography (USD MN)
  • Software & Services Market Sales By Geography (USD MN)
  • Global Market Analysis By Technology (USD MN)
  • Rational Protein Design Market Sales By Geography (USD MN)
  • Directed Evolution Market Sales By Geography (USD MN)
  • Hybrid Approach Market Sales By Geography (USD MN)
  • De Novo Protein Design Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Protein Type (USD MN)
  • Insulin Market Sales By Geography (USD MN)
  • Monoclonal Antibodies Market Sales By Geography (USD MN)
  • Vaccines Market Sales By Geography (USD MN)
  • Growth Factors Market Sales By Geography (USD MN)
  • Colony Stimulating Factors Market Sales By Geography (USD MN)
  • Coagulation Factors Market Sales By Geography (USD MN)
  • Interferon Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Academic Research Institutes Market Sales By Geography (USD MN)
  • Contract Research Organizations (CROs) Market Sales By Geography (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112114269

The global demand for Protein Engineering Market is presumed to reach the market size of nearly USD 8.74 Billion by 2032 from USD 2.09 Billion in 2023 with a CAGR of 17.23% under the study period 2024 - 2032.

Protein engineering is a biotechnology field focused on designing, modifying, and optimizing proteins for specific applications. It involves molecular modeling, rational design, directed evolution, and recombinant DNA technology to create proteins with desired properties and functionalities. It has diverse applications in medicine, agriculture, industry, and biotechnology, including developing therapeutic proteins, enzymes, vaccines, biosensors, and biomaterials. By harnessing the principles of protein structure and function, protein engineering enables the design of novel molecules with improved stability, activity, specificity, and other desired characteristics.

MARKET DYNAMICS

Increasing demand for therapeutic proteins and biopharmaceuticals for treating various diseases, including cancer, autoimmune disorders, and infectious diseases, drives the need for innovative protein engineering technologies to optimize protein function, stability, and pharmacokinetics. Additionally, advancements in protein engineering techniques, such as rational design, directed evolution, and computational modeling, enable the development of novel protein-based therapeutics with enhanced efficacy, specificity, and safety profiles. Furthermore, the growing investment in biotechnology research and development by pharmaceutical companies, academic institutions, and government agencies is fueling innovation and driving the commercialization of protein engineering technologies.

Moreover, the expanding applications of protein engineering beyond therapeutics, such as enzyme engineering for industrial biocatalysis, protein design for biomaterials and drug delivery systems, and protein optimization for agricultural biotechnology, are creating new market opportunities and driving growth. The increasing adoption of protein engineering technologies in personalized medicine, diagnostics, and regenerative medicine drives market expansion. Furthermore, strategic collaborations and partnerships among companies, biopharmaceutical firms, and research institutions are fostering innovation and accelerating the development and commercialization of protein-based products. However, concerns regarding privacy and data security in medical devices may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of protein engineering. The growth and trends of protein engineering industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the protein engineering market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Instruments
  • Reagents
  • Software & Services

By Technology

  • Rational Protein Design
  • Directed Evolution
  • Hybrid Approach
  • De Novo Protein Design
  • Others

By Protein Type

  • Insulin
  • Monoclonal Antibodies
  • Vaccines
  • Growth Factors
  • Colony Stimulating Factors
  • Coagulation Factors
  • Interferon
  • Others

By End-Use

  • Academic Research Institutes
  • Contract Research Organizations (Cros)
  • Pharmaceutical & Biotechnology Companies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Protein Engineering market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Protein Engineering market include Agilent Technologies, Bruker Corp., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Waters Corp., Bio-Rad Laboratories, Merck KGaA, Danaher Corp., Genscript Biotech Corp, Amgen Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. PROTEIN ENGINEERING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Technology
    • 3.7.3 Market Attractiveness Analysis By Protein Type
    • 3.7.4 Market Attractiveness Analysis By End-use
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PROTEIN ENGINEERING MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Product
  • 5.4. Instruments Historic and Forecast Sales By Regions
  • 5.5. Reagents Historic and Forecast Sales By Regions
  • 5.6. Software & Services Historic and Forecast Sales By Regions

6. GLOBAL PROTEIN ENGINEERING MARKET ANALYSIS BY TECHNOLOGY

  • 6.1. Overview By Technology
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Technology
  • 6.4. Rational Protein Design Historic and Forecast Sales By Regions
  • 6.5. Directed Evolution Historic and Forecast Sales By Regions
  • 6.6. Hybrid Approach Historic and Forecast Sales By Regions
  • 6.7. De Novo Protein Design Historic and Forecast Sales By Regions
  • 6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL PROTEIN ENGINEERING MARKET ANALYSIS BY PROTEIN TYPE

  • 7.1. Overview By Protein Type
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Protein Type
  • 7.4. Insulin Historic and Forecast Sales By Regions
  • 7.5. Monoclonal Antibodies Historic and Forecast Sales By Regions
  • 7.6. Vaccines Historic and Forecast Sales By Regions
  • 7.7. Growth Factors Historic and Forecast Sales By Regions
  • 7.8. Colony Stimulating Factors Historic and Forecast Sales By Regions
  • 7.9. Coagulation Factors Historic and Forecast Sales By Regions
  • 7.10. Interferon Historic and Forecast Sales By Regions
  • 7.11. Others Historic and Forecast Sales By Regions

8. GLOBAL PROTEIN ENGINEERING MARKET ANALYSIS BY END-USE

  • 8.1. Overview By End-use
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By End-use
  • 8.4. Academic Research Institutes Historic and Forecast Sales By Regions
  • 8.5. Contract Research Organizations (CROs) Historic and Forecast Sales By Regions
  • 8.6. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions

9. GLOBAL PROTEIN ENGINEERING MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE PROTEIN ENGINEERING COMPANIES

  • 10.1. Protein Engineering Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF PROTEIN ENGINEERING INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Agilent Technologies
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Bruker Corp.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Thermo Fisher Scientific Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. PerkinElmer Inc.
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Waters Corp.
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Bio-Rad Laboratories
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Merck KGaA
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Danaher Corp.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Genscript Biotech Corp
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Amgen Inc.
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies